Journal
NEURON
Volume 60, Issue 6, Pages 988-1009Publisher
CELL PRESS
DOI: 10.1016/j.neuron.2008.10.047
Keywords
-
Categories
Funding
- John Douglas French Foundation
- NIH [5T32AGO20506-04, 1F31AG030965-01A1, 5T32AGO00260, R01 AG022560, R01 AG030142]
- Deutsche Forschungsgerneinschaft [SFB 596]
- Federal Ministry of Education and Research
- Flemisch Government
Ask authors/readers for more resources
beta-site APP cleaving enzyme-1 (BACE1), the rate-limiting enzyme for beta-amyloid (A beta) production, is elevated in Alzheimer's disease (AD). Here, we show that energy deprivation induces phosphorylation of the translation initiation factor eIF2 alpha (eIF2 alpha-P), which increases the translation of BACE1. Salubrinal, an inhibitor of eIF2 alpha-P phosphatase PP1c, directly increases BACE1 and elevates A beta production in primary neurons. Preventing eIF2 alpha phosphorylation by transfection with constitutively active PP1c regulatory subunit, dominant-negative eIF2 alpha kinase PERK, or PERK inhibitor P58(IPK) blocks the energy-deprivation-induced BACE1 increase. Furthermore, chronic treatment of aged Tg2576 mice with energy inhibitors increases levels of eIF2 alpha-P, BACE1, A beta, and amyloid plaques. Importantly, eIF2 alpha-P and BACE1 are elevated in aggressive plaque-forming 5XFAD transgenic mice, and BACE1, eIF2 alpha-P, and amyloid load are correlated in humans with AD. These results strongly suggest that eIF2 alpha phosphorylation increases BACE1 levels and causes A beta overproduction, which could be an early, initiating molecular mechanism in sporadic AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available